Department of Urology, University of Arkansas for Medical Sciences, 4301 W Markham St, Little Rock, AR, 72205, USA.
Department of Endocrinology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
BMC Urol. 2023 Dec 8;23(1):204. doi: 10.1186/s12894-023-01370-y.
Pheochromocytoma is a neuroendocrine tumor, and its treatment is dependent on surgical resection. Due to the wide availability of cross-sectional imaging, pheochromocytomas are commonly seen as small tumors less than 10 cm in size and are mostly treated with minimally invasive surgery. Their concomitant presence with horseshoe kidney or other anatomical and vascular anomalies is rare. Herein, we present a surgically complex giant pheochromocytoma case who underwent an open left radical adrenalectomy.
A 41-year-old Hispanic female presented with a 12 × 8 cm left hypervascular adrenal mass, pelvic horseshoe kidney, and severely dilated large left retro-aortic renal vein which branched into a left adrenal vein, congested left ovarian vein, and left uterine plexus. She was managed with insulin and metformin for uncontrolled diabetes with an A1c level of 9% and doxazosin for persistent hypertension. Clinical diagnosis of pheochromocytoma was confirmed with elevated urine and serum metanephrine and normetanephrine. The pre-operative ACTH was within normal range with a normal dexamethasone suppression test and 24-hour urine free cortisol. The adrenalectomy of the highly aggressive adrenal mass was performed via open approach to obtain adequate surgical exposure. Due to the large size of the tumor and its significant involvement with multiple adjacent structures, coordination with multiple surgical teams and close hemodynamic monitoring by anesthesiology was required for successful patient outcomes including preservation of blood supply to the pelvic horseshoe kidney. The histopathological diagnosis was pheochromocytoma with negative surgical margins. The patient was followed at 1, 4, 12, and 24 weeks postoperatively. She had a normal postoperative eGFR and was able to discontinue antihypertensive and antidiabetic medications at four weeks. She had transient adrenal insufficiency, which resolved at five months. The horseshoe kidney was intact except for a minimal area of hypo-enhancement in the left superior renal moiety due to infarction, which was significantly improved at six months.
Our patient had a giant pheochromocytoma with anatomical variations complicating an already surgically challenging procedure. Nonetheless, with multiple provider collaboration, detailed pre-operative surgical planning, and meticulous perioperative monitoring, radical resection of the giant pheochromocytoma was safe and feasible with successful postoperative outcomes.
嗜铬细胞瘤是一种神经内分泌肿瘤,其治疗依赖于手术切除。由于横断面成像的广泛应用,嗜铬细胞瘤通常表现为小于 10cm 的小肿瘤,大多数采用微创手术治疗。它们与马蹄肾或其他解剖和血管异常同时存在的情况很少见。在此,我们报告了一例手术复杂的巨大嗜铬细胞瘤病例,该患者接受了开放性左肾上腺根治性切除术。
一名 41 岁的西班牙裔女性因左肾上腺有一个 12×8cm 的富血管性肿块、骨盆马蹄肾和严重扩张的左肾主动脉后大静脉而就诊,该静脉分支为左肾上腺静脉、充血的左卵巢静脉和左子宫丛。由于未控制的糖尿病(糖化血红蛋白水平为 9%)和持续性高血压,她接受了胰岛素和二甲双胍治疗。尿液和血清间甲肾上腺素和去甲肾上腺素升高,临床诊断为嗜铬细胞瘤。术前促肾上腺皮质激素(ACTH)在正常范围内,地塞米松抑制试验和 24 小时尿游离皮质醇正常。肾上腺切除术采用开放式方法对高度侵袭性肾上腺肿块进行,以获得足够的手术暴露。由于肿瘤体积大,且与多个相邻结构显著相关,需要多个手术团队的协调,并由麻醉科进行密切的血流动力学监测,以确保成功的手术结果,包括保持骨盆马蹄肾的血供。组织病理学诊断为嗜铬细胞瘤,切缘阴性。患者在术后 1、4、12 和 24 周进行了随访。术后她的肾小球滤过率(eGFR)正常,并在 4 周时停用了降压药和降糖药。她出现了短暂的肾上腺功能不全,在 5 个月时得到了缓解。马蹄肾完整,除左上部肾段因梗死而出现轻度强化减弱外。6 个月时明显改善。
我们的患者患有巨大的嗜铬细胞瘤,伴有解剖变异,使原本具有挑战性的手术更加复杂。尽管如此,通过多学科医生的合作、详细的术前手术计划和精细的围手术期监测,巨大嗜铬细胞瘤的根治性切除是安全可行的,术后结果良好。